Effectiveness of Multiple Blood-Cleansing Interventions in Sepsis, Characterized in Rats

Overview

Journal Sci Rep

Specialty Science

Date 2016 Apr 22

PMID 27097769

Authors

Ivan Stojkovic

Mohamed Ghalwash

Xi Hang Cao

Zoran Obradovic

Affiliations

Soon will be listed here.

Abstract

Sepsis is a serious, life-threatening condition that presents a growing problem in medicine, but there is still no satisfying solution for treating it. Several blood cleansing approaches recently gained attention as promising interventions that target the main site of problem development-the blood. The focus of this study is an evaluation of the theoretical effectiveness of hemoadsorption therapy and pathogen reduction therapy. This is evaluated using the mathematical model of Murine sepsis, and the results of over 2,200 configurations of single and multiple intervention therapies simulated on 5,000 virtual subjects suggest the advantage of pathogen reduction over hemoadsorption therapy. However, a combination of two approaches is found to take advantage of their complementary effects and outperform either therapy alone. The conducted computational experiments provide unprecedented evidence that the combination of two therapies synergistically enhances the positive effects beyond the simple superposition of the benefits of two approaches. Such a characteristic could have a profound influence on the way sepsis treatment is conducted.

References

Peng Z, Carter M, Kellum J . Effects of hemoadsorption on cytokine removal and short-term survival in septic rats. Crit Care Med. 2008; 36(5):1573-7. PMC: 3547590. DOI: 10.1097/CCM.0b013e318170b9a7. View

Cobb J, Hotchkiss R, Swanson P, Chang K, Qiu Y, Laubach V . Inducible nitric oxide synthase (iNOS) gene deficiency increases the mortality of sepsis in mice. Surgery. 1999; 126(2):438-42. View

Zuev S, Kingsmore S, Gessler D . Sepsis progression and outcome: a dynamical model. Theor Biol Med Model. 2006; 3:8. PMC: 1420276. DOI: 10.1186/1742-4682-3-8. View

Russel J . The current management of septic shock. Minerva Med. 2008; 99(5):431-58. View

Seok J, Warren H, Cuenca A, Mindrinos M, Baker H, Xu W . Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A. 2013; 110(9):3507-12. PMC: 3587220. DOI: 10.1073/pnas.1222878110. View

Peng Z, Wang H, Carter M, DiLeo M, Bishop J, Zhou F . Acute removal of common sepsis mediators does not explain the effects of extracorporeal blood purification in experimental sepsis. Kidney Int. 2011; 81(4):363-9. PMC: 3269547. DOI: 10.1038/ki.2011.320. View

Zanotti-Cavazzoni S, Goldfarb R . Animal models of sepsis. Crit Care Clin. 2009; 25(4):703-19, vii-viii. DOI: 10.1016/j.ccc.2009.08.005. View

Dellinger R, Levy M, Rhodes A, Annane D, Gerlach H, Opal S . Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013; 39(2):165-228. PMC: 7095153. DOI: 10.1007/s00134-012-2769-8. View

Liu V, Escobar G, Greene J, Soule J, Whippy A, Angus D . Hospital deaths in patients with sepsis from 2 independent cohorts. JAMA. 2014; 312(1):90-2. DOI: 10.1001/jama.2014.5804. View

10.

Poli-de-Figueiredo L, Garrido A, Nakagawa N, Sannomiya P . Experimental models of sepsis and their clinical relevance. Shock. 2008; 30 Suppl 1:53-9. DOI: 10.1097/SHK.0b013e318181a343. View

11.

Matsukawa A . STAT proteins in innate immunity during sepsis: lessons from gene knockout mice. Acta Med Okayama. 2007; 61(5):239-45. DOI: 10.18926/AMO/32897. View

12.

Rimmele T, Kellum J . Clinical review: blood purification for sepsis. Crit Care. 2011; 15(1):205. PMC: 3222040. DOI: 10.1186/cc9411. View

13.

Taniguchi T . Cytokine adsorbing columns. Contrib Nephrol. 2010; 166:134-141. DOI: 10.1159/000314863. View

14.

Levy M, Fink M, Marshall J, Abraham E, Angus D, Cook D . 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med. 2003; 29(4):530-8. DOI: 10.1007/s00134-003-1662-x. View

15.

Martin G . Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes. Expert Rev Anti Infect Ther. 2012; 10(6):701-6. PMC: 3488423. DOI: 10.1586/eri.12.50. View

16.

Thiel S, Rosini J, Shannon W, Doherty J, Micek S, Kollef M . Early prediction of septic shock in hospitalized patients. J Hosp Med. 2010; 5(1):19-25. DOI: 10.1002/jhm.530. View

17.

Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P . Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet. 2000; 356(9223):26-30. DOI: 10.1016/S0140-6736(00)02430-2. View

18.

Polaschegg H . Red blood cell damage from extracorporeal circulation in hemodialysis. Semin Dial. 2009; 22(5):524-31. DOI: 10.1111/j.1525-139X.2009.00616.x. View

19.

Nemzek J, Hugunin K, Opp M . Modeling sepsis in the laboratory: merging sound science with animal well-being. Comp Med. 2008; 58(2):120-8. PMC: 2703167. View

20.

Riedemann N, Guo R, Ward P . Novel strategies for the treatment of sepsis. Nat Med. 2003; 9(5):517-24. DOI: 10.1038/nm0503-517. View